Decreased galectin-3 expression in prostate cancer

Ronald A. Pacis, Mary Josephine Pilat, Kenneth J. Pienta, Kirk Wojno, Avraham Raz, Victor Hogan, Carlton R. Cooper

Research output: Contribution to journalArticle


BACKGROUND. Galectin-3 is a carbohydrate-binding protein whose level of expression has been shown to be correlated with metastatic potential in a number of different tumor types. The purpose of this investigation was to examine galectin-3 expression in several tumorigenic and nontumorigenic prostate cell lines and prostate tissue samples. METHODS. The expression of galectin-3 in cell lines and tissue samples was evaluated by tissue immunohistochemistry and Western blot analysis. RESULTS. Human cell lines PC- 3M, PC-3, DU-145, PrEC-1, and MCF10A demonstrated the presence of galectin-3. Galectin-3 was not detected in TSU-pr1 and LNCaP by Western blot analysis. We furthered our studies by examining a series of human prostate tissue samples for expression of galectin-3. Overall, approximately 60-70% of the normal tissue examined demonstrated heterogenous expression of galectin-3. In stage II tumors, however, there was a dramatic decrease in galectin-3 expression in both PIN and tumor sections, with only 10.5% (2/19) of these samples expressing this protein. Stage III tumors also demonstrated a decreased expression of galectin-3, although this downregulation was not as dramatic, with 35% of PIN samples and 52% of tumor tissue expressing galectin-3 (P < 0.01). CONCLUSIONS. These data demonstrate that galectin-3 is downregulated in prostate cancer. The altered downregulation pattern of galectin-3 observed between tumor stages suggests different roles for galectin-3 in the progression of prostate cancer. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)118-123
Number of pages6
Issue number2
StatePublished - Jul 1 2000



  • Adhesion molecules
  • Lectin
  • Prostate neoplasms

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Pacis, R. A., Pilat, M. J., Pienta, K. J., Wojno, K., Raz, A., Hogan, V., & Cooper, C. R. (2000). Decreased galectin-3 expression in prostate cancer. Prostate, 44(2), 118-123.<118::AID-PROS4>3.0.CO;2-U